The FDA no longer requires a safety warning on hormone-replacement therapies, at a time when more attention is being paid to perimenopause and menopause.
Source: MarketWatch
07. January 2026 16:56
The FDA no longer requires a safety warning on hormone-replacement therapies, at a time when more attention is being paid to perimenopause and menopause.
Source: MarketWatch